Enjoy complimentary customisation on priority with our Enterprise License!
The hematology analyzers and reagents market size is forecast to increase by USD 3.91 billion, at a CAGR of 6.95% between 2023 and 2028.
Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample
The market is characterized by its continuous evolution, driven by advancements in technology and regulatory requirements. CBC analyzers, for instance, are increasingly being integrated with automated systems, ensuring faster turnaround times and improved accuracy. IVD regulations, such as CLIA and CE marking, continue to shape the market, prioritizing regulatory compliance and quality assurance. Sample preparation and calibration fluids play a crucial role in maintaining the performance of these analyzers. Reagent management and inventory control are essential for ensuring a consistent supply of diagnostic reagents, while technical support and calibration services are vital for maintaining the accuracy and reliability of the systems.
Manual hematology systems and point-of-care testing are gaining popularity due to their ease of use and portability. Coagulation analyzers and immunohematology analyzers are also seeing significant growth, expanding the applications of hematology analyzers across various sectors. Platelet analyzers and differential analyzers are essential for diagnosing and monitoring blood disorders. Blood collection tubes and control materials are crucial components of the hematology analyzer system, ensuring accurate and reliable results. The market for hematology analyzers and reagents is dynamic, with ongoing developments in technology and regulatory requirements shaping its trajectory. The focus on improving turnaround time, ensuring regulatory compliance, and providing technical support and calibration services is driving innovation and growth in the market.
The hematology analyzers and reagents industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The reagents and consumables segment is estimated to witness significant growth during the forecast period.
The market encompasses various product segments, each playing a crucial role in ensuring accurate and efficient blood analysis. Reagents, specifically, are integral to the hematology system as they facilitate chemical reactions for identifying and measuring blood components. Hematology reagents, which include calibration fluids, control materials, and diagnostic reagents, are dedicated substances used in automated cell counters. Sample preparation is a critical process in hematology analysis, and the use of specialized reagents facilitates optimal sample handling. Compliance with regulations such as CLIA and IVD is essential, and reagents must undergo rigorous testing to meet quality assurance standards. Automated hematology systems, which include CBC analyzers, platelet analyzers, coagulation analyzers, and immunohematology analyzers, require regular maintenance and calibration services.
Reagent management systems ensure inventory control and timely replacement of consumables. Point-of-care testing has gained popularity due to its ease of use and quick turnaround time, necessitating the availability of diagnostic reagents and calibration services. Ease of use and CE marking are essential considerations for both manual and automated systems. Sample storage and transportation require specialized reagents and materials, such as blood collection tubes and control materials, to maintain sample integrity and prevent contamination. Regulatory compliance and quality control are paramount in the production and use of these reagents. Assay kits and inventory management systems facilitate efficient reagent utilization and reduce waste.
Technical support and calibration services ensure the continued performance of hematology analyzers and maintain the accuracy of results.
The Reagents and consumables segment was valued at USD 4.51 billion in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 37% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The North American the market is experiencing steady growth due to substantial investments in healthcare research and testing in the US. In 2020, the Centers for Medicare and Medicaid Services (CMS) reported a 2.7% increase in US national health expenditure spending, reaching USD4.3 trillion, or USD12,914 per person, contributing 18.3% to the country's gross domestic product. The well-established distribution network in countries like the US and Canada, along with manufacturers' focus on offering comprehensive hematology solutions, such as automated analyzers, to hospitals and diagnostic centers, is driving market expansion. Data management software plays a crucial role in ensuring regulatory compliance, including CLIA regulations, in the hematology analyzers market.
Reagent management, calibration fluids, and control materials are essential components of these systems, ensuring accurate and reliable results. Hematology analyzers, including CBC analyzers, platelet analyzers, hemoglobin analyzers, and coagulation analyzers, are integral to diagnosing various blood disorders. Automated hematology systems, with their ease of use and quick turnaround times, are increasingly popular. Point-of-care testing and manual hematology systems also have their place in the market, catering to specific needs. IVD regulations and quality assurance are critical factors influencing market trends. Inventory management and technical support are essential services provided by manufacturers to ensure seamless operations. Calibration services and assay kits are essential for maintaining the accuracy and reliability of hematology analyzers.
CE marking and quality control are crucial for regulatory compliance and ensuring the highest standards in the industry. Blood collection tubes and sample storage are vital components of the overall hematology solutions portfolio. The market is evolving, with a focus on providing integrated solutions that cater to various needs, from manual systems to automated, and from routine testing to specialized applications. Manufacturers are continually innovating to meet the demands of healthcare providers and diagnostic centers, ensuring the market remains dynamic and responsive to the needs of the industry.
The global hematology analyzers and reagents market is undergoing substantial growth, driven by the increasing need for accurate blood disorder diagnosis, including prevalent conditions like anemia diagnosis and severe illnesses such as blood cancer diagnosis. The expanding hematology analyzers and reagents market size and dynamic hematology analyzers and reagents market trends are fueled by strong hematology analyzers and reagents market growth drivers. Hematology analyzers, especially point-of-care (POC) hematology analyzers, are crucial for performing a complete blood count (CBC). The effectiveness of these devices relies heavily on specialized hematology reagents. Innovations like automated hematology analysis leveraging AI in hematology analysis and machine learning (ML) in hematology are transforming diagnostics. Furthermore, advancements in flow cytometry technology are vital. These tools are indispensable for infectious disease diagnosis, monitoring chronic conditions, and ensuring safe practices in blood bank testing, serving both clinical laboratories and hospitals (end-users).
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The hematology analyzers and reagents market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the hematology analyzers and reagents market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, hematology analyzers and reagents market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories - This company specializes in providing advanced hematology solutions, including analyzers like the CELL DYN Sapphire and CELL DYN Ruby, and accompanying reagents. Their offerings facilitate accurate and efficient blood cell analysis for various diagnostic applications.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Hematology Analyzers and Reagents Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
161 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6.95% |
|
Market growth 2024-2028 |
USD 3911.6 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
6.54 |
|
Key countries |
US, Canada, Germany, China, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this hematology analyzers and reagents market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Market Segmentation by Analyzer Type
9 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
